Where Science and Spirit Meet: The Intersection of Psychedelics and Epigenetics
David Rabin, MD, Ph.D. joins Paul Austin for a riveting conversation about the intersection of science and spirituality in psychedelic medicine.
In this episode, Paul and Dave discuss the first principles of healing trauma, the role psychedelics play in “meaning-making”, and how we can measure healing at the epigenetic level.
Dr. Rabin is the Chief Innovation Officer, Co-Founder, and Co-Inventor at Apollo Neuroscience, Inc., a biotechnology company focused on developing and commercializing non-invasive neuroenhancement technology for improving performance and recovery.
Dr. Rabin’s research focus is on the clinical translation of technologies that change the way people regulate thoughts and feelings in response to tactile stimulation and other non-invasive interventions.
In the clinic, Dr. Rabin studies novel therapies for treatment-resistant mental illnesses such as post-traumatic stress disorder, depression, anxiety, insomnia, and substance use disorders. He also works to identify new healthcare markets, to evaluate Apollo’s real-world efficacy through clinical trials, and to guide development of the Apollo technology.
- The first principles of healing trauma – and why adaptation is central to every healing process
- What role psychedelics play in making meaning out of life – and why this is critical to healing and transformation
- Dave’s new project – Apollo Neuroscience – which uses vibrations and cutting-edge neuroscience to improve human resilience